Masaki Hirota
- Molecular Biology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Surgery top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Kiyoyasu FukushimaPaul I. TerasakiDavid ChiaHiroyuki TogashiYasuo FukushiEdward NudelmanAkemi WakisakaSen‐itiroh Hakomori
- Topics
- Monoclonal and Polyclonal Antibodies Research (13 papers)Glycosylation and Glycoproteins Research (11 papers)Gastrointestinal Tumor Research and Treatment (10 papers)
In The Last Decade
Masaki Hirota
84 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Molecular Biology 806
- Radiology, Nuclear Medicine and Imaging 329
- Immunology 306
- Surgery 283
- Pulmonary and Respiratory Medicine 194
Countries citing papers authored by Masaki Hirota
This map shows the geographic impact of Masaki Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Hirota more than expected).
Fields of papers citing papers by Masaki Hirota
This network shows the impact of papers produced by Masaki Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Hirota. The network helps show where Masaki Hirota may publish in the future.
Co-authorship network of co-authors of Masaki Hirota
This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Hirota. A scholar is included among the top collaborators of Masaki Hirota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Hirota. Masaki Hirota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | [Two cases of human epidermal growth factor receptor 2-positive advanced gastric cancer successfully treated with S-1, cisplatin, and trastuzumab combination therapy followed by curative resection]. | 1 |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 79 | |
| 6 | 27 | |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 62 | |
| 10 | 13 | |
| 11 | 3 | |
| 12 | 1 | |
| 13 | 1 | |
| 14 | 1 | |
| 15 | 1 | |
| 16 | Detection of monoclonal antibodies for tumor diagnosis with the use of inhibition of micro-enzyme-linked immunosorbent assay. | 1 |
| 17 | 3 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 2 |
About Masaki Hirota
Masaki Hirota is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Surgery, having authored 101 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (11 papers) and Gastrointestinal Tumor Research and Treatment (10 papers). The work is most often cited by research in Immunology and Allergy (182 citations), Molecular Medicine (83 citations) and Immunology (306 citations). Masaki Hirota has collaborated with scholars based in Japan, Tunisia and Ethiopia. Frequent co-authors include Kiyoyasu Fukushima, Paul I. Terasaki, David Chia, Hiroyuki Togashi, Yasuo Fukushi, Edward Nudelman, Akemi Wakisaka, Sen‐itiroh Hakomori, Kohei Hara and Shigeru Kohno. Their work appears in journals such as Cancer, Biochimica et Biophysica Acta (BBA) - Biomembranes and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.